Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 292601 - 292620 out of 566296 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Greece | (L04AF07) deucravacitinib (adm: O) | SOTYKTU F.C.TAB 6MG/TAB BT X 28 (2 Χ 14) ΔΙΣΚΙΑ ΣΕ ΗΜΕΡΟΛΟΓΙΑΚΑ BLISTERS (PVC/PCTFE/ALU) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis | BRISTOL-MYERSSQUIBBPHARMAEEIG,IRELAND |
| Greece | (L04AF08) ritlecitinib (adm: O) | LITFULO CAPS 50MG/CAP BT X 30 ΚΑΨΑΚΙΑ ΣΕ ΚΥΨΕΛΗ (OPA/ALU/PVC/ALU) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Alopecia Areata | PFIZEREUROPEMAEEIG,BELGIUM |
| Greece | (L04AG03) natalizumab (adm: P) | TYSABRI C/S.SOL.IN 300MG/VIAL (20MG/ML) BT x 1 VIAL x 15 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Sclerosis | BIOGENNETHERLANDSB.V.,THENETHERLANDS |
| Greece | (L04AG03) natalizumab (adm: P) | TYSABRI® INJ.SOL 150MG/ML BT X 2 PF.SYR | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Sclerosis | BIOGENNETHERLANDSB.V.,THENETHERLANDS |
| Greece | (L04AG04) belimumab (adm: P) | BENLYSTA INJ.SOL 200MG/1ML BTx4 PF.PENS x1ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GLAXOSMITHKLINE(IRELAND)LIMITED,IRELAND |
| Greece | (L04AG05) vedolizumab (adm: P) | ENTYVIO INJ.SOL 108MG/0.68ML (158.8MG/ML) 1 PF. PEN (γυάλινη) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Colitis, Ulcerative;Crohn Disease | TAKEDAPHARMAA/S,DENMARK |
| Greece | (L04AG05) vedolizumab (adm: P) | ENTYVIO PD.C.S.INF 300MG/VIAL BTx1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Colitis, Ulcerative;Crohn Disease | TAKEDAPHARMAA/S,DENMARK |
| Greece | (L04AG06) alemtuzumab (adm: P) | LEMTRADA C/S.SOL.IN 12MG/VIAL BTx1VIALx1,2ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Sclerosis | SANOFIBELGIUM,BELGIUM |
| Greece | (L04AG08) ocrelizumab (adm: P) | OCREVUS C/S.SOL.IN 300MG/VIAL BTx1 VIAL x 10ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Sclerosis | ROCHEREGISTRATIONGMBH,GERMANY |
| Greece | (L04AG08) ocrelizumab (adm: P) | OCREVUS INJ.SOL 920MG/23ML (40MG/ML) BT X 1 VIAL X 23ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Sclerosis | ROCHEREGISTRATIONGMBH,GERMANY |
| Greece | (L04AG12) ofatumumab (adm: P) | KESIMPTA INJ.SOL 20MG/0,4 ML (50MG/ML) 1 PF. PEN x 0,4 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting | NOVARTISEUROPHARMLIMITED,IRELAND |
| Greece | (L04AG14) ublituximab | BRIUMVI C/S.SOL.IN 150MG/6ML (25MG/ML) BT X 1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting;Multiple Sclerosis | NEURAXPHARMPHARMACEUTICALSS.L.,BARCELONA,SPAIN |
| Greece | (L04AH01) sirolimus (adm: O) | RAPAMUNE C.TAB 1MG/TAB BTx30 σε BLISTER (PVC/PE/ACLAR/ALU) (PVC/PE/ACLAR/ALU) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Graft Rejection;Kidney Transplantation | PFIZEREUROPEMAEEIG,BELGIUM |
| Greece | (L04AH02) everolimus (adm: O) | CERTICAN TABLET 0,25MG/TAB BTx60 (BLIST.6x10) | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | NOVARTIS(HELLAS)A.E.B.E. |
| Greece | (L04AH02) everolimus (adm: O) | CERTICAN TABLET 0,5MG/TAB BTx60 (BLIST.6x10) | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | NOVARTIS(HELLAS)A.E.B.E. |
| Greece | (L04AH02) everolimus (adm: O) | CERTICAN TABLET 0,75MG/TAB BTx60 (BLIST.6x10) | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | NOVARTIS(HELLAS)A.E.B.E. |
| Greece | (L04AH02) everolimus (adm: O) | CERTICAN TABLET 1MG/TAB BTx60 BLIST.6x10) | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | NOVARTIS(HELLAS)A.E.B.E. |
| Greece | (L04AJ01) eculizumab (adm: P) | BEKEMV C/S.SOL.IN 300MG/30ML (10MG/ML) BT X 1 VIAL X 30ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Hemoglobinuria, Paroxysmal | AMGENTECHNOLOGYIRELAND,DUBLIN,IRELAND |
| Greece | (L04AJ02) ravulizumab (adm: P) | ULTOMIRIS® C/S.SOL.IN 1100MG/11ML BT X 1 VIAL X 11 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Hemoglobinuria, Paroxysmal | ALEXIONEUROPESAS,FRANCE |
| Greece | (L04AJ02) ravulizumab (adm: P) | ULTOMIRIS® C/S.SOL.IN 300MG/3ML BT X 1 VIAL X 3 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Hemoglobinuria, Paroxysmal | ALEXIONEUROPESAS,FRANCE |
Pages
